Leukokinins-clinical entities of neoplasia?
作者信息
Greenbaum L M
出版信息
Adv Exp Med Biol. 1976;70(00):315-8. doi: 10.1007/978-1-4684-3267-1_37.
PMID:59535
Abstract
摘要
相似文献
1
Leukokinins-clinical entities of neoplasia?白细胞激肽——肿瘤的临床实体？
Adv Exp Med Biol. 1976;70(00):315-8. doi: 10.1007/978-1-4684-3267-1_37.
2
Leukokinins; their pharmacological properties and role in the pathology of fluid (ascites) accumulation.
Agents Actions. 1978 Jan;8(1-2):80-4. doi: 10.1007/BF01972406.
3
4
Studies on leukokinins. II. Studies on the formation, partial amino acid sequence and chemical properties of leukokinins M and PMN.白细胞激肽研究。II. 白细胞激肽M和PMN的形成、部分氨基酸序列及化学性质研究
Biochem Pharmacol. 1972 Dec 1;21(23):3095-106. doi: 10.1016/0006-2952(72)90136-0.
5
Pepstatin, an inhibitor of leukokinin formation and ascitic fluid accumulation.
Cancer Res. 1975 Mar;35(3):706-10.
6
Pepstatin, an inhibitor of acid kininogenases and ascites retardant in neoplastic disease.
Fed Proc. 1979 Dec;38(13):2788-91.
7
Characteristics and isolation of the phagocytosis-stimulating peptide, tuftsin.
Biochim Biophys Acta. 1973 May 17;310(1):217-29. doi: 10.1016/0005-2795(73)90024-x.
8
Inhibition of basal and deprivation-induced proteolysis by leupeptin and pepstatin in perfused rat liver and heart.
Biochem Biophys Res Commun. 1979 Mar 15;87(1):92-8. doi: 10.1016/0006-291x(79)91651-6.
9
Purification and properties of a pepstatin-insensitive carboxyl proteinase from a gram-negative bacterium.来自革兰氏阴性细菌的一种胃蛋白酶抑制剂不敏感的羧基蛋白酶的纯化及性质
Biochim Biophys Acta. 1987 Mar 19;923(3):463-9. doi: 10.1016/0304-4165(87)90055-9.
10
The isolation of leukokinin-H and leukokininogen from human ascites fluid; their properties and role.从人腹水液中分离白细胞激肽-H和白细胞激肽原；它们的性质和作用。
Adv Exp Med Biol. 1979;120B:205-14.
Zotero 插件